During 2018 Q3 the big money sentiment increased to 1.17. That’s change of 0.14, from 2018Q2’s 1.03. 30 investors sold all, 84 reduced holdings as Sabra Health Care REIT, Inc. ratio increased. 81 grew stakes while 52 funds acquired stakes. Funds hold 158.92 million shares thus 1.61% more from 2018Q2’s 156.41 million shares.
Virginia Retirement System Et Al has 0.14% invested in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) for 540,810 shs. Metropolitan Life Insurance Co Ny accumulated 68,687 shs. Cohen & Steers has invested 1.45% of its capital in Sabra Health Care REIT, Inc. (NASDAQ:SBRA). Millennium Mgmt Ltd has 908,702 shs. Bankshares Of Mellon holds 0.02% or 2.65M shs in its capital. Dupont Cap has invested 0.01% in Sabra Health Care REIT, Inc. (NASDAQ:SBRA). Royal London Asset has 2,854 shs. Eii Cap Mgmt Inc invested in 0.29% or 23,899 shs. Fincl Svcs reported 0.01% stake. Moreover, Raymond James Associate has 0.05% invested in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) for 1.34 million shs. Cls Limited Liability Co owns 137 shs. 25.57 million are owned by Blackrock. 10,193 are held by Telemus Cap. Deutsche Bankshares Ag invested in 844,020 shs or 0.01% of the stock. Benjamin F Edwards & Company Inc holds 0% or 123 shs.

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) trading at $18.84 after decrease. On Feb, 25 the move was announced by Barchart.com. Sabra Health Care REIT, Inc. (NASDAQ:SBRA) has $3.36 billion market cap. $100.80 million less could be NASDAQ:SBRA valuation at $18.27 share price.

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Ratings Coverage

Total analysts of 4 have positions in Sabra Health Care REIT (NASDAQ:SBRA) as follows: 0 rated it a “Buy”, 1 with “Sell” and 3 with “Hold”. The positive are 0. Since September 19, 2018 according to StockzIntelligence Inc Sabra Health Care REIT has 4 analyst reports. On Friday, November 16 the company was downgraded by Raymond James. The company rating was downgraded by Bank of America on Friday, November 16. In Tuesday, November 13 report Mizuho downgraded it to “Neutral” rating and $21 target.

For more Sabra Health Care REIT, Inc. (NASDAQ:SBRA) news announced recently go to: Globenewswire.com, Seekingalpha.com, Seekingalpha.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “Sabra Reports Third Quarter 2018 Results and Continued Improvement in Skilled Nursing Occupancy, Skilled Mix and Senior Housing – Managed Portfolio Occupancy; Updates 2018 Guidance – GlobeNewswire” announced on November 05, 2018, “Sabra Health to sell Senior Care Centers portfolio – Seeking Alpha” on December 06, 2018, “Sabra Healthcare: When Disaster Strikes – Seeking Alpha” with a publish date: November 06, 2018, “Stepping Outside The Sabra Box – Seeking Alpha” and the last “Leerink sees 34% upside in Allergan in premarket analyst action – Seeking Alpha” with publication date: November 13, 2018.

Sabra Health Care REIT, Inc. operates as a real estate investment trust in the United States.The firm is valued at $3.36 billion. The company, through its subsidiaries, owns and invests in real estate properties for the healthcare industry.The P/E ratio is 8.62. The Company’s property portfolio consists of 86 properties comprising 67 skilled nursing facilities; 10 combined skilled nursing, assisted living, and independent living facilities; 5 assisted living facilities; 2 mental health facilities; 1 independent living facility; and 1 continuing care retirement community.